Vusolimogene oderparepvec (RP1) Clinical Trials

1 actively recruiting trial across 1 location

Filter by location:

Pittsburgh, Pennsylvania1 trial

RP1 in Primary Melanoma to Reduce the Risk of Sentinel Lymph Node Metastasis

UPMC Hillman Cancer Center

Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.